1Iki M,Morita A,Ikeda Y,et al.Biochemical markers of bone turnover predict bone loss in perimenopausal women but not in postmenopausal women-the Japanese Population-based Osteoporosis (JPOS) Cohort Study[J].Osteoporos Int,2006 Jul,17(7):1086-95.
2Rosenbrock H,et al.Changes of biochemical bone markers during the menopausal transition[J].Clin Chem Lab Med,2002 Feb,40(2):143-51.
3Seifert-Klauss V,et al.Bone metabolism during the perimenopausal transition:a prospective study[J].Maturitas,2002 Jan 30,41(1):23-33.
4Nakamura K,et al.Dietary calcium,sodium,phosphorus,and protein and bone metabolism in elderly Japanese women:a pilot study using the duplicate portion sampling method[J].Nutrition,2004 Apr,20(4):340-5.
5Bunout D,et al.Effect of a nutritional supplementation on bone health in chilean elderly subjects with femoral osteoporosis[J].J Am Coll Nutr,2006 Jun,25(3):170-7.
6Trovas GP,et al.A randomized trial of nasal spray salmon calcitonin in men with idiopathic osteoporosis:effects on bone mineral density and bone markers[J].J Bone Miner Res,2002 Mar,17(3):521-7.
7Nenonen A,et al.Serum TRACP 5b is a useful marker for monitoring alendronate treatment:comparison with other markers of bone turnover[J].J Bone Miner Res,2005 Oct,20(10):1804-12.
8Tsuchida T,et al.The clinical significance of serum osteocalcin and N-terminal propeptide of type I collagen in predialysis patients with chronic renal failure[J].Osteoporos Int,2005 Feb,16(2):172-9.
9Suzuki K,et al.Osteoclastic function is accelerated in male patients with type 2 diabetes mellitus:the preventive role of osteoclastogenesis inhibitory factor/osteoprotegerin (OCIF/OPG) on the decrease of bone mineral density[J].Diabetes Res Clin Pract,2005 May,68(2):117-25.
6Zaidi M, Shankar VS, Tunweil R, et al. A ryanodine receptor-like molecule expressed in the osteoclast plasma membrane functions in extracellular Ca2+ sensing. J Clin Invest. 1995;96(3): 1582-1590.
7Fuller K, Chambers TJ.Localisation of mRNA for collagenase in osteocytic, bone surface and chondrocytic cells but not osteoclasts.J Cell Sci. 1995;108 ( Pt 6):2221-2230.
8Looker AC, Bauer DC, Chesnut CH 3rd, et al. Clinical use of biochemical markers of bone remodeling: current status and future directions.Osteoporos I nt. 2000; 11 (6):467-480.
9Lewiecki EM, Laster AJ.Clinical review: Clinical applications of vertebral fracture assessment by dual-energy x-ray absorptiometry.J Clin Endocrinol Metab. 2006;91 (11 ):4215-4222.
10Sornay-Rendu E, Munoz F, Garnero P, et al. Identification of osteopenic women at high risk of fracture: the OFELY study.J Bone Miner Res. 2005;20(10):1813-1819.
